T1	CHEM 21 29	REFLUDAN
#1	AnnotatorNotes T1	C0661608
T2	CHEM 48 56	Refludan
#2	AnnotatorNotes T2	C0661608
T3	CHEM 61 69	Refludan
#3	AnnotatorNotes T3	C0661608
T4	CHEM 96 102	poudre
#4	AnnotatorNotes T4	C0032861
T5	OBJC 121 127	flacon
#5	AnnotatorNotes T5	C0179376
T6	PROC 138 147	dissoudre
#6	AnnotatorNotes T6	C1285147
T7	CHEM 165 184	solution injectable
#7	AnnotatorNotes T7	C0086466
T8	PROC 174 184	injectable
#8	AnnotatorNotes T8	C0021485
T9	PROC 188 198	perfusable
#9	AnnotatorNotes T9	C0031001
T10	PROC 201 231	goutte-à-goutte dans une veine
#10	AnnotatorNotes T10	C0021440
T11	ANAT 226 231	veine
#11	AnnotatorNotes T11	C0042449
T12	CHEM 242 256	principe actif
#12	AnnotatorNotes T12	C1372955
T13	CHEM 264 274	lépirudine
#13	AnnotatorNotes T13	C0772394
T14	CHEM 294 302	Refludan
#14	AnnotatorNotes T14	C0661608
T15	CHEM 322 330	Refludan
#15	AnnotatorNotes T15	C0661608
T16	PHYS 360 371	coagulation
#16	AnnotatorNotes T16	C0005778
T17	LIVB 381 389	patients
#17	AnnotatorNotes T17	C0030705
T18	DISO 402 443	thrombocytopénie induite par l ’ héparine
#18	AnnotatorNotes T18	C0272285
T19	DISO 402 418	thrombocytopénie
#19	AnnotatorNotes T19	C0040034
T20	CHEM 435 443	héparine
#20	AnnotatorNotes T20	C0019134
T21	DISO 451 454	TIH
#21	AnnotatorNotes T21	C0272285
T22	DISO 496 504	allergie
#22	AnnotatorNotes T22	C0020517
T23	CHEM 522 530	héparine
#23	AnnotatorNotes T23	C0019134
T24	DISO 556 587	carence de plaquettes sanguines
#24	AnnotatorNotes T24	C0392386
T25	ANAT 567 587	plaquettes sanguines
#25	AnnotatorNotes T25	C0005821
T26	DISO 608 616	caillots
#26	AnnotatorNotes T26	C0302148
T27	ANAT 626 644	vaisseaux sanguins
#27	AnnotatorNotes T27	C0005847
T28	DISO 653 660	maladie
#28	AnnotatorNotes T28	C0012634
T29	DISO 653 677	maladie thromboembolique
#29	AnnotatorNotes T29	C0040038
T30	DISO 705 713	caillots
#30	AnnotatorNotes T30	C0302148
T31	ANAT 717 721	sang
#31	AnnotatorNotes T31	C0005767
T32	PROC 739 749	traitement
#32	AnnotatorNotes T32	C0087111
T33	CHEM 750 766	antithrombotique
#33	AnnotatorNotes T33	C1704311
T34	CHEM 771 780	injection
#34	AnnotatorNotes T34	C0086466
T35	CHEM 803 811	héparine
#35	AnnotatorNotes T35	C0019134
T36	DISO 819 829	diagnostic
#36	AnnotatorNotes T36	C0011900
T37	PROC 857 862	tests
#37	AnnotatorNotes T37	C0683443
T38	PROC 889 893	test
#38	AnnotatorNotes T38	C0683443
T39	PHYS 951 974	activation plaquettaire
#39	AnnotatorNotes T39	C0032173
T40	ANAT 962 974	plaquettaire
#40	AnnotatorNotes T40	C00058213
T41	CHEM 991 999	héparine
#41	AnnotatorNotes T41	C0019134
T42	CHEM 1012 1020	Refludan
#42	AnnotatorNotes T42	C0661608
T43	CHEM 1040 1048	Refludan
#43	AnnotatorNotes T43	C0661608
T44	PROC 1053 1063	administré
#44	AnnotatorNotes T44	C1533734
T45	CHEM 1068 1077	injection
#45	AnnotatorNotes T45	C0086466
T46	PROC 1085 1108	perfusion intraveineuse
#46	AnnotatorNotes T46	C0021440
T47	PROC 1085 1094	perfusion
#47	AnnotatorNotes T47	C0031001
T48	PROC 1111 1141	goutte-à-goutte dans une veine
#48	AnnotatorNotes T48	C0021440
T49	ANAT 1136 1141	veine
#49	AnnotatorNotes T49	C0042449
T50	PROC 1150 1160	traitement
#50	AnnotatorNotes T50	C0087111
T51	CHEM 1165 1173	Refludan
#51	AnnotatorNotes T51	C0661608
T52	LIVB 1215 1222	médecin
#52	AnnotatorNotes T52	C0031831
T53	PROC 1252 1262	traitement
#53	AnnotatorNotes T53	C0087111
T54	PHYS 1269 1280	coagulation
#54	AnnotatorNotes T54	C0005778
T55	DISO 1296 1304	caillots
#55	AnnotatorNotes T55	C0302148
T56	ANAT 1305 1313	sanguins
#56	AnnotatorNotes T56	C0005767
T57	PHYS 1363 1377	poids corporel
#57	AnnotatorNotes T57	C0005910
T58	DISO 1403 1426	injection intraveineuse
#58	AnnotatorNotes T58	C0542046
T59	PHYS 1457 1471	poids corporel
#59	AnnotatorNotes T59	C0005910
T60	PROC 1485 1494	perfusion
#60	AnnotatorNotes T60	C0031001
T61	LIVB 1616 1624	patients
#61	AnnotatorNotes T61	C0030705
T63	DISO 1638 1653	troubles rénaux
#63	AnnotatorNotes T63	C0022658
T64	ANAT 1647 1653	rénaux
#64	AnnotatorNotes T64	C0022646
T65	CHEM 1666 1674	Refludan
#65	AnnotatorNotes T65	C0661608
T66	CHEM 1698 1708	lépirudine
#66	AnnotatorNotes T66	C0772394
T67	CHEM 1711 1725	principe actif
#67	AnnotatorNotes T67	C0013161
T68	CHEM 1729 1737	Refludan
#68	AnnotatorNotes T68	C0661608
T69	CHEM 1770 1778	hirudine
#69	AnnotatorNotes T69	C0019573
T70	CHEM 1781 1805	substance anticoagulante
#70	AnnotatorNotes T70	C0003280
T71	LIVB 1823 1831	sangsues
#71	AnnotatorNotes T71	C0023209
T72	CHEM 1839 1849	lépirudine
#72	AnnotatorNotes T72	C0772394
T73	LIVB 1872 1878	levure
#73	AnnotatorNotes T73	C0043393
T74	CHEM 1900 1903	ADN
#74	AnnotatorNotes T74	C0012854
T75	CHEM 1957 1967	lépirudine
#75	AnnotatorNotes T75	C0772394
T76	PHYS 2045 2056	coagulation
#76	AnnotatorNotes T76	C0005778
T77	CHEM 2062 2071	thrombine
#77	AnnotatorNotes T77	C0040018
T78	PHYS 2133 2153	coagulation sanguine
#78	AnnotatorNotes T78	C0005778
T79	ANAT 2145 2153	sanguine
#79	AnnotatorNotes T79	C0005767
T80	CHEM 2158 2166	Refludan
#80	AnnotatorNotes T80	C0661608
T81	PHYS 2197 2208	coagulation
#81	AnnotatorNotes T81	C0005778
T82	CHEM 2256 2264	Refludan
#82	AnnotatorNotes T82	C0661608
T83	PROC 2271 2277	étudié
#83	AnnotatorNotes T83	C2603343
T84	PROC 2295 2301	essais
#84	AnnotatorNotes T84	C2603343
T85	LIVB 2317 2325	patients
#85	AnnotatorNotes T85	C0030705
T86	PROC 2334 2340	études
#86	AnnotatorNotes T86	C2603343
T87	PHYS 2366 2371	décès
#87	AnnotatorNotes T87	C0011065
T88	PROC 2378 2389	amputations
#88	AnnotatorNotes T88	C0002688
T89	DISO 2407 2438	complications thromboemboliques
#89	AnnotatorNotes T89	C0040038
T90	DISO 2407 2420	complications
#90	AnnotatorNotes T90	C0009566
T91	PHYS 2441 2452	coagulation
#91	AnnotatorNotes T91	C0005778
T92	CHEM 2496 2504	Refludan
#92	AnnotatorNotes T92	C0661608
T93	PROC 2518 2524	études
#93	AnnotatorNotes T93	C2603343
T94	PROC 2589 2595	essais
#94	AnnotatorNotes T94	C2603343
T95	CHEM 2674 2682	Refludan
#95	AnnotatorNotes T95	C0661608
T96	DISO 2709 2740	complications thromboemboliques
#96	AnnotatorNotes T96	C0040038
T97	DISO 2709 2722	complications
#97	AnnotatorNotes T97	C0009566
T98	DISO 2815 2822	risques
#98	AnnotatorNotes T98	C0184544
T99	CHEM 2834 2842	Refludan
#99	AnnotatorNotes T99	C0661608
T100	CHEM 2871 2900	médicaments antithrombotiques
#100	AnnotatorNotes T100	C1704311
T101	CHEM 2883 2900	antithrombotiques
#101	AnnotatorNotes T101	C1704311
T102	DISO 2907 2923	effet secondaire
#102	AnnotatorNotes T102	C0543419
T103	CHEM 2956 2964	Refludan
#103	AnnotatorNotes T103	C0661608
T104	LIVB 2993 3000	patient
#104	AnnotatorNotes T104	C0030705
T105	DISO 3018 3028	saignement
#105	AnnotatorNotes T105	C0019080
T106	DISO 3040 3050	saignement
#106	AnnotatorNotes T106	C0019080
T107	PHYS 3065 3070	décès
#107	AnnotatorNotes T107	C0011065
T108	LIVB 3110 3117	patient
#108	AnnotatorNotes T108	C0030705
T109	DISO 3164 3183	effets indésirables
#109	AnnotatorNotes T109	C0559546
T110	PROC 3184 3192	observés
#110	AnnotatorNotes T110	C0302523
T111	CHEM 3198 3206	Refludan
#111	AnnotatorNotes T111	C0661608
T112	PROC 3237 3243	notice
#112	AnnotatorNotes T112	C0013191
T113	CHEM 3257 3265	Refludan
#113	AnnotatorNotes T113	C0661608
T114	DISO 3323 3341	maladie très grave
#114	AnnotatorNotes T114	C0010340
T115	DISO 3323 3330	maladie
#115	AnnotatorNotes T115	C0012634
T116	PROC 3378 3388	traitement
#116	AnnotatorNotes T116	C0087111
T117	CHEM 3414 3425	médicaments
#117	AnnotatorNotes T117	C0013227
T118	CHEM 3483 3491	Refludan
#118	AnnotatorNotes T118	C0661608
T119	DISO 3514 3521	risques
#119	AnnotatorNotes T119	C0184544
T120	PROC 3530 3540	traitement
#120	AnnotatorNotes T120	C0087111
T121	LIVB 3545 3553	patients
#121	AnnotatorNotes T121	C0030705
T123	DISO 3567 3608	thrombocytopénie induite par l ’ héparine
#123	AnnotatorNotes T123	C2349404 C0272285
T125	DISO 3567 3583	thrombocytopénie
#125	AnnotatorNotes T125	C0040034
T126	CHEM 3600 3608	héparine
#126	AnnotatorNotes T126	C0019134
T127	DISO 3615 3639	maladie thromboembolique
#127	AnnotatorNotes T127	C0040038
T128	DISO 3615 3622	maladie
#128	AnnotatorNotes T128	C0012634
T129	CHEM 3732 3740	Refludan
#129	AnnotatorNotes T129	C0661608
T130	CHEM 3777 3785	Refludan
#130	AnnotatorNotes T130	C0661608
T131	GEOG 3822 3832	européenne
#131	AnnotatorNotes T131	C0015176
T132	GEOG 3905 3921	Union européenne
#132	AnnotatorNotes T132	C0015179
T133	CHEM 3927 3935	Refludan
#133	AnnotatorNotes T133	C0661608
T134	CHEM 3982 3990	Refludan
#134	AnnotatorNotes T134	C0661608
T135	CHEM 4018 4026	Refludan
#135	AnnotatorNotes T135	C0661608
T136	CHEM 4037 4043	poudre
#136	AnnotatorNotes T136	C0032861
T137	CHEM 4049 4068	solution injectable
#137	AnnotatorNotes T137	C0086466
T138	PROC 4058 4068	injectable
#138	AnnotatorNotes T138	C0021485
T139	PROC 4077 4086	perfusion
#139	AnnotatorNotes T139	C0031001
T140	OBJC 4096 4102	flacon
#140	AnnotatorNotes T140	C0179376
T141	CHEM 4121 4131	lépirudine
#141	AnnotatorNotes T141	C0772394
T142	CHEM 4141 4151	lépirudine
#142	AnnotatorNotes T142	C0772394
T143	CHEM 4167 4170	ADN
#143	AnnotatorNotes T143	C0012854
T144	CHEM 4193 4211	cellules de levure
#144	AnnotatorNotes T144	C0669253
T145	ANAT 4193 4201	cellules
#145	AnnotatorNotes T145	C0007634
T146	LIVB 4205 4211	levure
#146	AnnotatorNotes T146	C0043393
T147	CHEM 4228 4247	solution injectable
#147	AnnotatorNotes T147	C0086466
T148	PROC 4237 4247	injectable
#148	AnnotatorNotes T148	C0021485
T149	PROC 4256 4265	perfusion
#149	AnnotatorNotes T149	C0031001
T150	CHEM 4270 4276	Poudre
#150	AnnotatorNotes T150	C0032861
T151	PHYS 4340 4350	Inhibition
#151	AnnotatorNotes T151	C0021469
T152	PHYS 4357 4368	coagulation
#152	AnnotatorNotes T152	C0005778
T153	LIVB 4378 4386	patients
#153	AnnotatorNotes T153	C0030705
T154	LIVB 4387 4394	adultes
#154	AnnotatorNotes T154	C0001765
T155	PHYS 4431 4445	poids corporel
#155	AnnotatorNotes T155	C0005910
T156	LIVB 4449 4456	patient
#156	AnnotatorNotes T156	C0030705
T157	LIVB 4474 4482	patients
#157	AnnotatorNotes T157	C0030705
T158	LIVB 4565 4573	patients
#158	AnnotatorNotes T158	C0030705
T159	PROC 4647 4657	traitement
#159	AnnotatorNotes T159	C0087111
T160	CHEM 4662 4670	Refludan
#160	AnnotatorNotes T160	C0661608
T161	PROC 902 944	heparin induced platelet aggregation assay
#161	AnnotatorNotes T161	C0919798
T162	PROC 889 899	test HIPAA
#162	AnnotatorNotes T162	C0919798
T163	PROC 1485 1517	perfusion intraveineuse continue
#163	AnnotatorNotes T163	C0021440
